Geddes Colin C, Henderson Andrew, Mackenzie Pamela, Rodger Stuart C
Renal Unit, Western Infirmary, Glasgow, United Kingdom.
Transplantation. 2008 Oct 27;86(8):1143-5. doi: 10.1097/TP.0b013e318187cdd0.
The aim of this study was to analyze the 3-year outcome of patients traveling from the west of Scotland to Pakistan for living donor kidney transplant. Baseline data and outcomes of 18 consecutive recipients who traveled to Pakistan between 2000 and 2007 and returned for follow-up at the regional transplant unit in the west of Scotland were retrieved from the electronic patient record. Mean follow-up was 775 days. No patients died. Two kidneys failed at 12 and 1400 days, respectively. The incidence of acute rejection in the first year was 11.1%. Mean eGFR at 1 and 3 years were 51.8 and 47.7 mL/min/1.73 m2, respectively. One patient developed malaria. No patients contracted hepatitis B, hepatitis C, or human immunodeficiency virus infection. The outcomes of this series of patients are better than previous reports and can be used to inform patients who ask for advice about the risks of traveling abroad for kidney transplantation.
本研究的目的是分析从苏格兰西部前往巴基斯坦接受活体供肾移植的患者的3年预后情况。从电子病历中检索了2000年至2007年间前往巴基斯坦并返回苏格兰西部地区移植单位进行随访的18例连续受者的基线数据和预后情况。平均随访时间为775天。无患者死亡。分别有2例肾脏在12天和1400天时出现功能衰竭。第一年急性排斥反应的发生率为11.1%。1年和3年时的平均估算肾小球滤过率(eGFR)分别为51.8和47.7 mL/min/1.73 m²。1例患者患疟疾。无患者感染乙型肝炎、丙型肝炎或人类免疫缺陷病毒。这一系列患者的预后情况优于以往报告,可用于为寻求出国肾移植风险建议的患者提供参考。